- Treatment with ruxolitinib cream (Opzelura™) resulted in facial repigmentation at Week 24, characterized by a significant proportion of patients achieving ≥75% improvement from baseline in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback